Celgene Corporation

At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients. Headquartered in Summit, New Jersey, USA, Celgene is an integrated biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.
Summit, US
6,971 (est)
Celgene Corporation was founded in 1986 and is headquartered in Summit, US

Celgene Corporation Locations

Summit, US

Celgene Corporation Metrics

Celgene Corporation Summary

Market capitalization

$87.1 B

Closing share price

Celgene Corporation's current market capitalization is $87.1 B.

Celgene Corporation Market Value History

Celgene Corporation Online Presence

Celgene Corporation News

Celgene Corporation Company Life

You may also be interested in